Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BUILD-A-BEAR WORKSHOP INC Major Shareholding Notification 2023

Jan 11, 2023

32281_mrq_2023-01-11_f435efca-9482-404a-b836-e188101cd853.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

SC 13D/A 1 sc13da811527013_01112023.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 8) 1

Build-A-Bear Workshop, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

120076104

(CUSIP Number)

MR. DAVID L. KANEN

KANEN WEALTH MANAGEMENT, LLC

5850 Coral Ridge Drive, Suite 309

Coral Springs, FL 33076

(631) 863-3100

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

January 10, 2023

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨ .

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

Field: Rule-Page

Field: /Rule-Page

1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ).

Field: Page; Sequence: 1

CUSIP No. 120076104

Field: /Page

NAME OF REPORTING PERSON
PHILOTIMO FUND, LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
(b) ☐
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY - 0 -
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 302,130
PERSON WITH 9 SOLE DISPOSITIVE POWER
- 0 -
10 SHARED DISPOSITIVE POWER
302,130
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
302,130
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.0%
14 TYPE OF REPORTING PERSON
IA, PN

Field: Page; Sequence: 2

2

CUSIP No. 120076104

Field: /Page

NAME OF REPORTING PERSON
KANEN WEALTH MANAGEMENT, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
(b) ☐
3 SEC USE ONLY
4 SOURCE OF FUNDS
OO; AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
FLORIDA
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY - 0 -
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 859,211
PERSON WITH 9 SOLE DISPOSITIVE POWER
- 0 -
10 SHARED DISPOSITIVE POWER
859,211
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
859,211
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.8%
14 TYPE OF REPORTING PERSON
IA, OO

Field: Page; Sequence: 3

3

CUSIP No. 120076104

Field: /Page

NAME OF REPORTING PERSON
DAVID L. KANEN
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
(b) ☐
3 SEC USE ONLY
4 SOURCE OF FUNDS
PF; OO
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY 738
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 859,211
PERSON WITH 9 SOLE DISPOSITIVE POWER
738
10 SHARED DISPOSITIVE POWER
859,211
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
859,949
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.8%
14 TYPE OF REPORTING PERSON
IN

Field: Page; Sequence: 4

4

CUSIP No. 120076104

Field: /Page

NAME OF REPORTING PERSON
PHILOTIMO FOCUSED GROWTH AND INCOME FUND
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
(b) ☐
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 214,670
PERSON WITH 9 SOLE DISPOSITIVE POWER
-0-
10 SHARED DISPOSITIVE POWER
214,670
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
214,670
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.5%
14 TYPE OF REPORTING PERSON
IA, OO

Field: Page; Sequence: 5

5

CUSIP No. 120076104

Field: /Page

This Amendment No. 8 to the Schedule 13D filed by the undersigned (“Amendment No. 8”) is being filed to report additional transactions since and to correct a scrivener’s error as to certain information in the transaction schedule of the Shares beneficially owned by the Reporting Persons in Amendment No. 7. This Amendment No. 8 amends the Schedule 13D as specifically set forth herein.

Item 3. Source and Amount of Funds or Other Consideration .

Item 3 is hereby amended and restated to read as follows:

The Shares purchased by Philotimo were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by PHLOX were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by KWM were purchased with the funds for the accounts of its customers (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The Shares purchased by Mr. Kanen were purchased with personal funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 342,411 Shares beneficially owned by KWM is approximately $2,615,232, including brokerage commissions. The aggregate purchase price of the 302,130 Shares beneficially owned by Philotimo is approximately $1,130,979, including brokerage commissions. The aggregate purchase price of the 214,670 Shares beneficially owned by PHLOX is approximately $3,154,486, including brokerage commissions. The aggregate purchase price of the 738 Shares beneficially owned by Mr. Kanen is approximately $4,794, including brokerage commissions.

Item 5. Interest in Securities of the Issuer .

Items 5(a)-(c) are hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each person named herein is based upon 14,750,444 Shares outstanding, as of December 5, 2022 which is the total number of Shares outstanding as reported in the Issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on December 5, 2023.

A. Philotimo

(a) As of the close of business on January 10, 2023, Philotimo beneficially owned 302,130 Shares.

Percentage: Approximately 2.0%

(b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 302,130 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 302,130

(c) Philotimo has not made any transactions in the Shares since Amendment No. 7.

Field: Page; Sequence: 6

6

CUSIP No. 120076104

Field: /Page

B. KWM

(a) As of the close of business on January 10, 2023, KWM directly beneficially owned 342,411 Shares. KWM, as the general partner of Philotimo, may be deemed the beneficial owner of the 302,130 Shares owned by Philotimo. KWM, as the advisor to the fund for PHLOX may be deemed the beneficial owner of the 214,670 Shares owned by PHLOX.

Percentage: Approximately 5.8%

(b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 859,211 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 859,211

(c) KWM has not made any transactions in the Shares since Amendment No. 7. The transactions in the Shares on behalf of PHLOX since Amendment No. 7 are set forth in Schedule A and are incorporated herein by reference.

C. Mr. Kanen

(a) As of the close of business on January 10, 2023, Mr. Kanen directly beneficially owned 738 Shares. Mr. Kanen, as the managing member of KWM, may be deemed the beneficial owner of the (i) 342,411 Shares owned by KWM, (ii) 302,130 Shares owned by Philotimo, and (iii) 214,670 Shares owned by PHLOX.

Percentage: Approximately 5.8%

(b) 1. Sole power to vote or direct vote: 738 2. Shared power to vote or direct vote: 859,211 3. Sole power to dispose or direct the disposition: 738 4. Shared power to dispose or direct the disposition: 859,211

(c) Mr. Kanen has not made any transactions in the Shares since Amendment No. 7. The transactions in the Shares on behalf of PHLOX during the past sixty days are set forth in Schedule A and are incorporated herein by reference.

D. PHLOX

(a) As of the close of business on January 10, 2023, PHLOX beneficially owned 214,670 Shares.

Percentage: 1.5%

(b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 214,670 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 214,670

(c) The transactions in the Shares by PHLOX since Amendment No. 7 are set forth in Schedule A and are incorporated herein by reference.

Field: Page; Sequence: 7

7

CUSIP No. 120076104

Field: /Page

KWM, in its role as investment manager to several customer accounts (collectively, the “ Accounts ”) to which it furnishes investment advice, and Mr. Kanen, as the managing member of KWM, may each be deemed to beneficially own shares of the Issuer’s Shares held in the Accounts.

Each Reporting Person, as a member of a “group” with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, may be deemed the beneficial owner of the Shares directly owned by the other Reporting Persons. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.

Field: Page; Sequence: 8

8

CUSIP No. 120076104

Field: /Page

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: January 11, 2023

/s/ David L. Kanen
Name: David L. Kanen
Title: Managing Member
Philotimo Fund, LP — By: Kanen Wealth Management, LLC, its general partner
By: /s/ David L. Kanen
Name: David L. Kanen
Title: Managing Member
Philotimo Focused Growth and Income Fund — By: Kanen Wealth Management, LLC, its investment adviser
By: /s/ David L. Kanen
Name: David L. Kanen
Title: Managing Member
/s/ David L. Kanen
David L. Kanen

Field: Page; Sequence: 9

9

CUSIP No. 120076104

Field: /Page

SCHEDULE A

Transactions in the Shares of the Issuer During the Past Sixty Days

Nature of the Transaction Amount of Shares Purchased/(Sold) Price ($) Date of Purchase/Sale

PHILOTIMO FOCUSED GROWTH AND INCOME FUND

Sale of Common Stock (3,961) 24.5004 01/03/2023
Sale of Common Stock (24,251) 24.6523 01/04/2023
Sale of Common Stock (12,777) 24.5442 01/05/2023
Sale of Common Stock (25,000) 24.7707 01/06/2023
Purchase of Common Stock 21,485 23.4946 01/09/2023
Purchase of Common Stock 6,574 23.4858 01/10/2023